BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9401789)

  • 1. Reversal of tolerance to the antitransit effects of morphine during acute intestinal inflammation in mice.
    Pol O; Puig MM
    Br J Pharmacol; 1997 Nov; 122(6):1216-22. PubMed ID: 9401789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal inflammation enhances the inhibitory effects of opioids on intestinal permeability in mice.
    Valle L; Pol O; Puig MM
    J Pharmacol Exp Ther; 2001 Feb; 296(2):378-87. PubMed ID: 11160621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral effects of opioids in a model of chronic intestinal inflammation in mice.
    Puig MM; Pol O
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1068-75. PubMed ID: 9864294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice.
    Pol O; Ferrer I; Puig MM
    J Pharmacol Exp Ther; 1994 Jul; 270(1):386-91. PubMed ID: 8035336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
    Alonzo NC; Bayer BM
    J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice.
    Pol O; Sasaki M; Jiménez N; Dawson VL; Dawson TM; Puig MM
    Br J Pharmacol; 2005 Jul; 145(6):758-66. PubMed ID: 15852037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
    Tiseo PJ; Inturrisi CE
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of NMDA receptors in morphine state-dependent learning in mice.
    Zarrindast MR; Jafari-Sabet M; Rezayat M; Djahanguiri B; Rezayof A
    Int J Neurosci; 2006 Jun; 116(6):731-43. PubMed ID: 16753898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal inflammation and morphine tolerance alter the interaction between morphine and clonidine on gastrointestinal transit in mice.
    Puig MM; Warner W; Pol O
    Anesthesiology; 2000 Jul; 93(1):219-30. PubMed ID: 10861166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diabetes on the morphine-induced inhibition of gastrointestinal transit.
    Kamei J; Ohsawa M; Misawa M; Nagase H; Kasuya Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):165-9. PubMed ID: 7796321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
    Dunbar SA; Pulai IJ
    J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effects of alpha(2)-adrenoceptor agonists on gastrointestinal transit during croton oil-induced intestinal inflammation.
    Pol O; Valle L; Ferrer I; Puig MM
    Br J Pharmacol; 1996 Dec; 119(8):1649-55. PubMed ID: 8982514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice.
    Iijima Y; Asami T; Kuribara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):11-8. PubMed ID: 8640458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
    Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
    Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats.
    Calcina F; Barocelli E; Bertoni S; Furukawa O; Kaunitz J; Impicciatore M; Sternini C
    Neuroscience; 2005; 134(1):39-49. PubMed ID: 15939544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies and antisense oligodeoxynucleotides to mu-opioid receptors, selectively block the effects of mu-opioid agonists on intestinal transit and permeability in mice.
    Pol O; Valle L; Sánchez-Blázquez P; Garzón J; Puig MM
    Br J Pharmacol; 1999 May; 127(2):397-404. PubMed ID: 10385239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.
    Leal MB; Michelin K; Souza DO; Elisabetsky E
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):781-5. PubMed ID: 12921910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
    Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.